Latest Articles
Married to Medicine’s Lateasha Lunceford Shares Update on Growing Her Family With Dr. Greg - Reality Tea
Married to Medicine’s Lateasha Lunceford Shares Update on Growing Her Family With Dr. Greg Reality Tea
Published: Feb. 5, 2025, 3:18 p.m.
NJUGUSH and WAKAVINYE pay tribute to JAHMBY KOIKAI with second Matatu named after their son TORIA (PHOTOs $ VIDEO) - DAILY POST
NJUGUSH and WAKAVINYE pay tribute to JAHMBY KOIKAI with second Matatu named after their son TORIA (PHOTOs $ VIDEO) DAILY POST
Published: Feb. 5, 2025, 2:07 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - StreetInsider.com
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent StreetInsider.com
Published: Feb. 5, 2025, 1:51 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Yahoo Finance
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent Yahoo Finance
Published: Feb. 5, 2025, 1:51 p.m.
Women’s health is missing in action from the government’s new NHS priorities - Cosmopolitan UK
Women’s health is missing in action from the government’s new NHS priorities Cosmopolitan UK
Published: Feb. 5, 2025, 1:47 p.m.
Women’s health is missing in action from the new NHS priorities - Cosmopolitan UK
Women’s health is missing in action from the new NHS priorities Cosmopolitan UK
Published: Feb. 5, 2025, 1:47 p.m.
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting - Cureus
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting Cureus
Published: Feb. 5, 2025, 1:26 p.m.
Acrivon Therapeutics Announces FDA has Granted Breakthrough - GlobeNewswire
Acrivon Therapeutics Announces FDA has Granted Breakthrough GlobeNewswire
Published: Feb. 5, 2025, 1:19 p.m.
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times
Published: Feb. 5, 2025, 1:07 p.m.
An Echo Press Editorial: 8 essential ways to lower stroke risk - Alexandria Echo Press
An Echo Press Editorial: 8 essential ways to lower stroke risk Alexandria Echo Press
Published: Feb. 5, 2025, 1:04 p.m.
Link copied to clipboard!